Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM
Status:
Available
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in
changing the Glycated Hb Level in Diabetes mellitus Type II.
Abstract:
Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in
the world in this century, and accounts for 90% of cases of diabetes globally. Studies have
suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim
of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through
GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.